Skip to Main Content

Mycobacteria, Advanced Microscopy, & Cell Metabolism - The Rego Lab at Yale School of Medicine

May 19, 2025
ID
13149

Transcript

  • 00:05Mycobacteria
  • 00:06are a group of bacteria
  • 00:07and there's lots of different
  • 00:09types.
  • 00:10Many of them are found
  • 00:11in soil and water and
  • 00:12are essentially harmless
  • 00:14to most people. But there
  • 00:16are a few mycobacteria
  • 00:17that actually cause very devastating
  • 00:19human diseases and one of
  • 00:20the most famous is mycobacterium
  • 00:22tuberculosis
  • 00:23which causes tuberculosis.
  • 00:25There's another mycobacteria called mycobacterium
  • 00:27leprae that cause the disease
  • 00:28leprosy.
  • 00:35There are several unique features.
  • 00:37First is that different from
  • 00:38other bacteria it has a
  • 00:40very unusual cell wall or
  • 00:42cell envelope architecture.
  • 00:44And the cell envelope is
  • 00:46basically the thing that coats
  • 00:47the bacterium and protects it
  • 00:49and interfaces
  • 00:50with the environment.
  • 00:52Mycobacteria
  • 00:52have a very unusual
  • 00:54structure to its cell envelope.
  • 00:56It's very thick, it's very
  • 00:57waxy, and we think that
  • 00:59that prevents a lot of
  • 01:00antibiotics from actually getting into
  • 01:01the bacterium
  • 01:03to reach their target and
  • 01:04to kill the bacterium. And
  • 01:05then the second feature that
  • 01:06we think is really unusual
  • 01:08to mycobacteria
  • 01:08is that even
  • 01:10in a genetically identical population,
  • 01:13mycobacteria seem very good at
  • 01:14generating a lot of diversity
  • 01:17in different physiological
  • 01:18properties.
  • 01:20We think that differences in
  • 01:21in these mycobacterial
  • 01:23populations at the single cell
  • 01:24level can be really important
  • 01:26for the bacteria
  • 01:28to tolerate antibiotics, meaning that
  • 01:30there are some bacteria
  • 01:32that can survive antibiotic pressure
  • 01:35simply because they phenotypically
  • 01:36look a little different than
  • 01:38others.
  • 01:39How are individual mycobacteria
  • 01:41different? How do they differ
  • 01:43in the responses to antibiotics?
  • 01:44What are the underlying causes
  • 01:46of those differences?
  • 01:47We think a lot of
  • 01:48it traces down to metabolism
  • 01:50and so my lab is
  • 01:50really trying to understand the
  • 01:52metabolism
  • 01:53of individual mycobacteria.
  • 02:00We use microscopes to answer
  • 02:02those questions.
  • 02:04That can range from simple
  • 02:05time lapse videos where we
  • 02:07look at individual cells over
  • 02:09time. And because some of
  • 02:11them can grow and divide
  • 02:12really slowly, we have to
  • 02:13run our microscopes for up
  • 02:14to five days in order
  • 02:15to,
  • 02:16capture the cell growth and
  • 02:17and division of these of
  • 02:19these organisms. But we also
  • 02:20use, super resolution microscopy to
  • 02:22understand the spatial organization
  • 02:25of proteins within the cell.
  • 02:27We also started using these
  • 02:29fluorescent reporters or sensors
  • 02:31for different metabolic properties of
  • 02:33the cell.
  • 02:35For example, we have used
  • 02:36a fluorescent reporter for, ATP,
  • 02:38which is the energy currency
  • 02:40of the cell. And so
  • 02:41now we can measure ATP
  • 02:42levels
  • 02:43in individual cells, and understand
  • 02:46how differences in in,
  • 02:48say, ATP or other metabolites
  • 02:50are generated in a clonal
  • 02:52population and what are the
  • 02:53consequences for having different levels
  • 02:55of of these metabolites.
  • 03:03Our goals are treating some
  • 03:05of these mycobacterial
  • 03:06infections.
  • 03:07Tuberculosis
  • 03:08kills more people each year
  • 03:09than any other single infectious
  • 03:11disease, and in history has
  • 03:12actually killed more people than
  • 03:14any single infectious disease. So
  • 03:16it's an incredible global health
  • 03:18problem.
  • 03:19If someone gets TB,
  • 03:21they have to go on
  • 03:22a course of antibiotic therapy
  • 03:24that can last anywhere from
  • 03:25four to six months with
  • 03:26a combination
  • 03:27of four antibiotics,
  • 03:29which as you can imagine
  • 03:30is a very long time
  • 03:31to be on antibiotic therapy.
  • 03:34We think that if there
  • 03:35are all these differences
  • 03:37in metabolism
  • 03:38and physiology
  • 03:40of that bacterial population,
  • 03:42then we think that if
  • 03:43we can transition
  • 03:45cells or force cells into
  • 03:47a more antibiotic favorable state
  • 03:49that we might be able
  • 03:50to treat an infection more
  • 03:51rapidly.